Completed OBSERVATIONAL NCT07426653
Predicting Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Using Machine Learning Models.
Clinicopathology-based Machine Learning Model for Prediction of Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer
Sponsor: Florence Nightingale Hospital, Istanbul
Conditions
Breast Cancer
Updated 1 time since 2026 Last updated: Feb 15, 2026 Started: Jan 1, 2010 Primary completion: Dec 31, 2025 Completion: Dec 31, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This observational or N/A phase trial investigates Breast Cancer and is currently completed. Florence Nightingale Hospital, Istanbul leads this study, which shows 1 recorded version since 2010 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
1 version recorded Completed
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Florence Nightingale Hospital, Istanbul
Data source: Florence Nightingale Hospital, Istanbul
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.